publication venue for
- NLRP3 inflammasome activity is required for wound healing after burns. 217:47-60. 2020
- Airway and serum adipokines after allergen and diesel exposure in a controlled human crossover study of atopic adults. 182:49-60. 2017
- Keloids: what do we know and what do we do next?. 159:173-174. 2012
- Reduction of arterial graft smooth muscle mass by moderate heat therapy. 157:128-138. 2011
- Reduction of arterial graft smooth muscle mass by moderate heat therapy.. 157:128-138. 2011
- Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors. 147:27-35. 2006
- Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?. 146:341-346. 2005
- Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: effluxing fibrin(ogen) fragments contain antiangiogenic activity. 143:241-254. 2004
- A covalently linked recombinant albumin dimer is more rapidly cleared in vivo than are wild-type and mutant C34A albumin. 143:115-124. 2004
- Delivery of recombinant gene product to canine brain with the use of microencapsulation. 142:399-413. 2003
- Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function. 140:391-397. 2002
- Angiostatin II is the predominant glycoform in pleural effusates of rabbit VX-2 lung tumors. 139:316-323. 2002
- Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics. 139:35-42. 2002
- Metabolism of rabbit angiostatin glycoforms I and II in rabbits: Angiostatin-I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin-II. 138:83-93. 2001
- Delivery of recombinant product from subcutaneous implants of encapsulated recombinant cells in canines. 135:484-492. 2000
- Plasminogen II accumulates five times faster than plasminogen I at the site of a balloon de-endothelializing injury in vivo to the rabbit aorta: Comparison with other hemostatic proteins. 134:260-266. 1999
- Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders. 133:129-133. 1999
- Uptake of heparin cofactor II and antithrombin into the aorta wall after a deendothelializing injury in vivo: Comparison with the behaviors of prothrombin and fibrinogen. 133:81-87. 1999
- Hirudin causes more bleeding than heparin in a rabbit ear bleeding model. 132:181-185. 1998
- ABH antigens on human platelets: Expression on the glycosyl phosphatidylinositol-anchored protein CD109. 132:142-148. 1998
- The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance. 130:649-655. 1997
- Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia. 130:278-284. 1997
- Heparin-induced thrombocytopenia: What the serologists have taught us. 128:346-348. 1996
- Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio. 128:214-217. 1996
- Interaction of low molecular weight heparin with ketorolac. 127:583-587. 1996
- Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.. 126:521-529. 1995
- Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.. 125:212-221. 1995
- New anticoagulant strategies.. 122:364-373. 1993
- Catabolism of unglycated and naturally glycated forms of rabbit fibrinogen: their interaction with the healthy and deendothelialized aorta wall in normal and diabetic rabbits.. 121:588-597. 1993
- Regulation of lithium and boron levels in normal human blood: environmental and genetic considerations.. 121:614-619. 1993
- Antibody-mediated platelet activation.. 121:382-384. 1993
- Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.. 121:64-70. 1993
- Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.. 120:371-379. 1992
- Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state.. 119:221-230. 1992
- High hemoglobin A2 beta-thalassemia.. 118:382. 1991
- Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.. 117:359-364. 1991
- The effect of alpha-hemoglobin gene deletions on the red blood cells' mean cell volume and hemoglobin levels.. 116:573-574. 1990
- What stimulates atrial natriuretic factor release during exercise?. 116:487-491. 1990
- Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin.. 115:356-364. 1990
- Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemia.. 115:241-248. 1990
- Leukocyte endogenous mediator fails to alter protein dynamics in a model of liver dysfunction.. 113:211-220. 1989
- Standard assays underestimate the concentration of heparin in neonatal plasma.. 112:641-643. 1988
- Lithium and boron in human blood.. 109:155-158. 1987
- Putative role for lithium in human hematopoiesis.. 109:159-163. 1987
- Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.. 103:606-612. 1984
- Plasma fibronectin level and clinical status in cardiac surgery patients.. 102:881-889. 1983
- The development and application of a serum assay for platelet-bindable IgG (S-PBIgG).. 98:272-279. 1981
- Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium.. 96:861-870. 1980
- Heterogeneity of rat liver parenchymal cells: cell volume as a function of DNA content.. 94:718-725. 1979
- Effects of phenobarbital and 3-methylcholanthrene pretreatment on size, sedimentation velocity, and mixed function oxygenase activity of rat hepatocytes.. 91:444-454. 1978
- Studies using sedimentation velocity on heterogeneity of size and function of hepatocytes from mature male rats.. 91:432-443. 1978
- Increased heparin clearance in experimental pulmonary embolism.. 90:204-215. 1977
- Determination of hemoglobin-oxygen affinity on micro samples.. 85:329-336. 1975
- The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.. 82:255-266. 1973
- Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi in rabbits.. 72:245-255. 1968
- THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.. 65:713-731. 1965
- CARDIORESPIRATORY RESPONSE OF VERY OBESE SUBJECTS TO TREADMILL EXERCISE.. 64:107-116. 1964
- Reduced membrane fluidity and increased glycation of membrane proteins of plaelets from diabetic subjects are not associated with increased platelet adherence to glycated collagen \textbar Request PDF. 120:921-928. 1992
- Platelet survival in rats with spontaneous diabetes mellitus. 109:454-463. 1987
- Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. 107:148-153. 1986
- Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats. 107:154-158. 1986
- Changes in the properties of platelets from rats with experimentally induced shortened platelet survival \textbar Request PDF. 101:175-182. 1983
- Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. 97:680-688. 1981
- Quantitative radioisotopic measurement and scaning electron microscopic study of platelet adherence to a collagen-coated surface and to subendothelium with a rotating probe device \textbar Request PDF. 93:60-70. 1979
- Mechanism of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187 \textbar Request PDF. 90:707-719. 1977
- Adenine nucleotides in thrombin-degranulated platelets: Effect of prolonged circulation in vivo. 90:490-501. 1977
- Platelet factor 3 availability and the platelet release reaction. 84:474-482. 1974
- The effect of glucose on the platelet response to release-inducing stimuli. 80:247-255. 1972
- The effect of glucose on adenosine diphosphate-induced platelet aggregation. 75:780-787. 1970